We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
A Concerto HealthAI-Pfizer joint steering committee will oversee the collaboration. The first outcomes research and publications are expected in early 2020.
Bristol-Myers Squibb and Concerto HealthAI have announced plans to apply artificial intelligence (AI) and real-world data to a diverse range of cancers in a multi-year strategic agreement.